StockData
Biodesix Inc logo

Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.88−0.12 (-1.33%)

Close on Nov 17, 2026Market cap $93.69MP/E –Yield –

Biodesix market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Biodesix's market cap was $106.76M on Nov 11, 2026, against $65.86M a year earlier. Over the last 5 years it ranged from $54.09M to $5.69B, with a median of $1.51B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$106.76M+97.4%
2025Dec 31, 2025$54.09M-98.8%
2024Dec 31, 2024$4.45B+37.0%
2023Dec 29, 2023$3.25B+71.5%
2022Dec 30, 2022$1.89B-33.7%
2021Dec 31, 2021$2.86B+2349.0%
2020Dec 31, 2020$116.73M–

More Biodesix figures

See a number that looks wrong?